6/25/2019 12:22:07 PM - Reported earnings +3% on +7% sales revenues for the Mar &#39;19 quarter. Fundamental concerns remain as the firm&#39;s prior quarterly earnings increases were below the +25% minimum guideline (C criteria) and sales revenues growth rate is not a match with the fact-based investment system&#39;s guidelines.<br><hr>1/9/2019 12:39:23 PM - Slumped below its 200 DMA line in recent weeks. Reported earnings +2% on +7% sales revenues for the Sep &#39;18 quarter.  Noted in the 7/17/18 mid-day report while challenging its April &#39;16 all-time high - <i>&quot;Fundamental concerns remain as the firm&#39;s prior quarterly earnings increases were below the +25% minimum guideline (C criteria) and sales revenues growth rate is not a match with the fact-based investment system&#39;s guidelines.&quot;</i><br><hr>12/10/2018 12:41:08 PM - Reported earnings +2% on +7% sales revenues for the Sep &#39;18 quarter. Rebounding toward its prior high. Went through a deep slump below its 200 DMA line after last noted in the 7/17/18 mid-day report while challenging its April &#39;16 all-time high - <i>&quot;Fundamental concerns remain as the firm&#39;s prior quarterly earnings increases were below the +25% minimum guideline (C criteria) and sales revenues growth rate is not a match with the fact-based investment system&#39;s guidelines.&quot;</i><br><hr>7/17/2018 11:51:41 AM - Reported earnings +8% on +7% sales revenues for the Mar &#39;18 quarter. Pulling back below its 50 DMA line ($31.20) after recently challenging its April &#39;16 all-time high. Recently rallying near its 52-week high. Fundamental concerns remain as the firm&#39;s prior quarterly earnings increases were below the +25% minimum guideline (C criteria) and sales revenues growth rate is not a match with the fact-based investment system&#39;s guidelines.<br><hr>5/4/2018 12:22:58 PM - Reported earnings +8% on +7% sales revenues for the Mar &#39;18 quarter. Recently rallying near its 52-week high. Fundamental concerns remain as the firm&#39;s prior quarterly earnings increases were below the +25% minimum guideline (C criteria) and sales revenues growth rate is not a match with the fact-based investment system&#39;s guidelines.<br><hr>4/30/2018 12:21:47 PM - Reported earnings +8% on +7% sales revenues for the Mar &#39;18 quarter. rallying near its 52-week high. Fundamental concerns remain as the firm&#39;s prior quarterly earnings increases were below the +25% minimum guideline (C criteria) and sales revenues growth rate is not a match with the fact-based investment system&#39;s guidelines.<br><hr>